Creative Medical Technology Holdings, Inc.

CELZ Healthcare Biotechnology

Creative Medical Technology Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6,000.00, down 45.5% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 14.6% and free cash flow fell 27.1%, each against the same quarter a year earlier.

0.74 0.08 −9.76%
Market cap
$5.4M
P/E
0.0×
Fwd P/E
−1.3×
Dividend yield
—
F-score
4/9
Altman Z
−4.32
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
— — 5 —

+8 more TTM periods

ROE
(77.91%) (81.19%) (86.47%) (98.14%)
ROA
(73.30%) (77.93%) (82.81%) (93.58%)
ROIC
0.00% (1,304.33%) (1,213.03%) (1,758.41%)
Return on Tangible Assets
(72.60%) (100.19%) (84.27%) (115.75%)
Average Days of Receivables
— — 0.00 —
Free Cash Flow per Share
(1.59) (1.51) (2.46) (2.27)
Free Cash Flow
(5.90) (5.59) (5.86) (5.87)
Other line items

Show all line items

Columns are period end dates